Market Overview

Novo Nordisk Posts 29% Surge In Q2 Profit, Lifts Forecast

Share:
Related NVO
5 NYSE Healthcare Stocks With The Highest ROI
Conquering Hemophilia: Novo Nordisk Reports Encouraging Data From Phase III Trial Of NovoEight
Six International Leaders Preparing To Report Results (Investor's Business Daily)

Novo Nordisk A/S (NYSE: NVO) reported a 29% rise in its second-quarter net profit and lifted its full-year forecast.

Novo Nordisk's quarterly net profit surged to DKK5.35 billion, versus DKK4.13 billion, in the year-ago period. However, analysts were expecting a net profit of DKK4.87 billion.

Its sales climbed 22% to DKK19.47 billion from DKK16 billion, versus analysts' estimates of DKK18.73 billion. Novo Nordisk's EBIT jumped 45% to DKK7.65 billion, versus DKK5.27 billion.

Novo Nordisk shares closed at $154.41 yesterday.

Posted-In: profitEarnings News

 

Related Articles (NVO)

Get Benzinga's Newsletters